Stay updated on Dolutegravir Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.

Latest updates to the Dolutegravir Rilpivirine Clinical Trial page
- Check5 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2. This reflects a new page build rather than changes to the study details.SummaryDifference0.0%

- Check12 days agoChange DetectedRemoved the Lancet citation for the SWORD-1/SWORD-2 studies from the Publications section.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, signaling completion; it also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the heading to an Intervention/Treatment section, with a revision label of Revision: v3.6.0.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision stamp updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page's revision history.SummaryDifference0.0%

- Check48 days agoChange DetectedPage revision tag was updated from v3.5.3 to v3.5.4, signaling a new page version. No substantive changes to study details or visible content are indicated in the provided changes.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page footer revision/version number was updated from v3.5.0 to v3.5.3, reflecting an interface or system release rather than any clinical study content change.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Rilpivirine Clinical Trial page.